Create Medic Co., Ltd. (5187) AI Stock Analysis

0 Followers

Create Medic Co., Ltd.

(TSE/TYO:5187)

Select Model

Rating:55Neutral

Price Target:JPY 1,139.00▲(4.11% Upside)

Action:reiterated

Date:11/06/26

The overall score of 55 reflects a company with a solid financial foundation but significant operational headwinds. The primary strength is a pristine balance sheet, which provides stability. However, this is heavily counterbalanced by weak technical momentum and volatile, low-quality earnings and cash flows. The attractive dividend yield offers some support but is not enough to offset the prevailing risks.

Positive Factors

Steady Revenue GrowthConsistent top-line growth demonstrates ongoing customer demand for the company’s products and provides a stable base for planning. Although growth is modest, its continuity supports operating resilience and gives management a platform for improving profitability over the next several quarters.

Negative Factors

Volatile ProfitabilityUneven profitability reduces the quality and predictability of the company’s otherwise steady revenue base. Inconsistent operating profit suggests that cost control or other expenses can absorb growth, making earnings less dependable and limiting visibility into sustainable returns.

Create Medic Co., Ltd. (5187) vs. iShares MSCI Japan ETF (EWJ)

Market Cap: JPY 8.76B
Dividend Yield: 4.39%
Average Volume (3M): 4,506
Price to Earnings (P/E): 25.6
Beta (1Y): 0.30
Revenue Growth: 3.38%
EPS Growth: -52.61%
Country: Japan
Employees: 1,010
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Specialties

Create Medic Co., Ltd. Business Overview & Revenue Model

Company Description

Create Medic Co., Ltd. engages in the research, manufacturing, and sale of medical appliances in Japan, China, Vietnam, and internationally. The company offers urology products, including all silicone foley, antibacterial foley, hematuria, tieman, su...

How the Company Makes Money

Create Medic primarily makes money by selling medical devices and single-use medical consumables to healthcare providers (e.g., hospitals and clinics) through domestic and export distribution channels. Its core revenue comes from recurring demand for...

Create Medic Co., Ltd. Financial Statement Overview

Summary

The company has a very strong, low-leverage balance sheet (Score 82), but this is offset by modest and volatile earnings (Income Score 58) and weak, inconsistent cash flow generation (Cash Flow Score 48). The overall financial picture is stable but lacks robust profitability and cash conversion.

Income Statement

58Neutral

Balance Sheet

82Very Positive

Cash Flow

48Neutral

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	14.03B	13.62B	13.03B	12.59B	12.33B	11.70B
Gross Profit	5.71B	5.99B	5.70B	5.48B	5.37B	5.26B
EBITDA	1.21B	1.64B	1.73B	1.50B	1.47B	1.43B
Net Income	348.91M	713.73M	840.90M	154.02M	482.21M	660.41M
Balance Sheet
Total Assets	19.83B	20.14B	20.05B	19.26B	19.12B	18.08B
Cash, Cash Equivalents and Short-Term Investments	5.49B	5.83B	6.32B	4.39B	4.31B	4.36B
Total Debt	749.70M	749.70M	891.96M	884.78M	933.42M	815.36M
Total Liabilities	3.68B	3.81B	4.30B	4.31B	4.40B	3.86B
Stockholders Equity	16.15B	16.33B	15.75B	14.94B	14.72B	14.22B
Cash Flow
Free Cash Flow	0	98.51M	1.77B	246.98M	101.75M	629.58M
Operating Cash Flow	0	530.12M	2.25B	698.84M	461.34M	1.25B
Investing Cash Flow	0	-573.08M	270.62M	-363.61M	38.01M	-585.01M
Financing Cash Flow	0	-600.39M	-877.65M	-362.19M	-355.59M	-442.52M

Create Medic Co., Ltd. Technical Analysis

Technical Analysis SentimentNegative

Last Price1094.00

Price Trends

50DMA1129.90Negative

100DMA1127.81Negative

200DMA1126.75Negative

Market Momentum

MACD-10.66Positive

RSI41.23Neutral

STOCH26.06Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5187, the sentiment is Negative. The current price of 1094.00 is below the 20-day moving average (MA) of 1108.75, below the 50-day MA of 1129.90, and below the 200-day MA of 1126.75, indicating a bearish trend. The MACD of -10.66 indicates Positive momentum. The RSI at 41.23 is Neutral, neither overbought nor oversold. The STOCH value of 26.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:5187.

Create Medic Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

JP:5187 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JP:6678	82Outperform	JPY 18.43B	12.29	―	5.97%	17.11%	23.02%
JP:6849	63Neutral	JPY 245.91B	20.56	―	2.11%	-0.18%	-33.38%
JP:5187	55Neutral	JPY 9.90B	25.64	―	4.39%	3.38%	-52.61%
JP:6523	55Neutral	JPY 178.77B	17.72	5.56%	3.27%	2.74%	145.33%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
JP:4549	50Neutral	JPY 71.94B	39.73	―	2.60%	3.92%	-52.01%
JP:7600	45Neutral	JPY 8.27B	-5.33	―	5.41%	-8.68%	-75.03%

* Healthcare Sector Average

Performance Comparison

JP:5187 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
JP:5187	Create Medic Co., Ltd.	1094.00	127.73	13.22%
JP:6523	PHC Holdings Corp.	1284.00	365.93	39.86%
JP:4549	Eiken Chemical Co., Ltd.	2233.00	-88.60	-3.82%
JP:6678	Techno Medica Co., Ltd.	2149.00	266.95	14.18%
JP:6849	Nihon Kohden Corporation	1518.50	-27.11	-1.75%
JP:7600	Japan Medical Dynamic Marketing, Inc.	315.00	-167.41	-34.70%

Create Medic Co., Ltd. Corporate Events

Create Medic Sales Rise as Nine-Month Profit Plunges

Nov 2, 2026

Create Medic reported nine-month net sales of ¥10.467 billion for the period ended September 30, 2026, up 4.1% year on year. Operating profit fell 44.2% to ¥509 million, ordinary profit declined 34.8% to ¥568 million, and profit attributable to owner...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 05, 2026

Create Medic Co., Ltd. AI Stock Analysis